Showing results (221-230 of 424) with videos related to
Sort By:
Pageof 43
Oncology Reports|August 9, 2002
Expression of collagen type II, S100B, S100A2 and osteocalcin in chondroblastoma and chondromyxoid fibromaHye-Rim Park, Yong-Koo Park, Kee Taek Jang, et al.Biomaterials|November 7, 2002
Fibrinolysis inhibitors adversely affect remodeling of tissues sealed with fibrin glueLissy K Krishnan, Arthur Vijayan Lal, P R Uma Shankar, et al.Indian Journal of Pharmaceutical Sciences|November 27, 2014
Design, Synthesis, Toxicity Estimation and Molecular Docking Studies of N-(furan-2-yl)-1-(5-substituted) phenyl-1,3,4-oxadiazol-2-yl) methanimine as Antitubercular AgentsB Mathew, J Suresh, Githa E Mathew, et al.Reviews in Cardiovascular Medicine|May 17, 2017
Spontaneous Coronary Artery Dissection: Insights From Histology and Optical Coherence TomographySandeep K Krishnan, Alex Zhu, Brent Larson, et al.Functional & Integrative Genomics|May 5, 2017
Comprehensive strategy for the design of precision drugs and identification of genetic signature behind proneness of the disease-a pharmacogenomic approachPreethi M Iyer, S Karthikeyan, P Sanjay Kumar, et al.Leukemia|March 1, 1996
A mutant form of p135tyk2, an interferon-alpha inducible tyrosine kinase, suppresses the transformed phenotype of Daudi cellsE Davis, K Krishnan, H Yan, et al.Journal of Biomedical Materials Research. Part B, Applied Biomaterials|June 12, 2008
Development of a fibrin composite-coated poly(epsilon-caprolactone) scaffold for potential vascular tissue engineering applicationsDivya Pankajakshan, Lizymol P Philipose, Minshiya Palakkal, et al.The Indian Journal of Medical Research|February 1, 1997
Morphological & ultrastructural changes of platelet concentrates stored in PVC bagsL K Krishnan, P V Sulochana, J Mathai, et al.Current Drug Targets|January 17, 2003
Cancer chemoprevention drug targetsK Krishnan, S Campbell, F Abdel-Rahman, et al.Pageof 43